Africa CDC Accuses US Government of Creating Panic in Travel Advisory Over Rwanda Marburg Outbreak 10/10/2024 Paul Adepoju The Africa CDC has slammed the US government’s recent Level 3 travel advisory for Rwanda as unfair and baseless, arguing it undermines Rwanda’s proactive efforts to contain a Marburg outbreak. With rapid testing, vaccinations, and coordinated emergency response measures in place, Rwanda’s leaders insist the country poses no international threat and warn that travel restrictions […] Continue reading -> New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Alzheimer’s Advocates Urge G7 to Accelerate Research and Healthcare Preparedness 09/10/2024 Maayan Hoffman Helen Rochford-Brennan, a 72-year-old Irish woman living with Alzheimer’s, was first diagnosed at 57, with a more complete diagnosis following five years later. At the time, there were no life-enhancing medications, leaving her to face the grim reality of her brain’s gradual decline, enduring what she described as “many dark days.” “Imagine having a new […] Continue reading -> Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> World Leaders Approve Milestone Commitment to Reduce Deaths from Antibiotic Resistance by 10% by 2030 26/09/2024 Elaine Ruth Fletcher A UN High Level Meeting on Antimicrobial Resistance (AMR) pledged to reduce by 10% deaths from drug resistant bacteria over the next six years in a new declaration on the “silent, slow-motion pandemic” that could kill some 39 million more people by 2050. Thursday’s milestone statement, the first on the topic since 2016, also pledges […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New and More Effective Vaccine Strategies Could Reduce Antibiotics Use by One-Fifth: New WHO Analysis 10/10/2024 Elaine Ruth Fletcher Better use of existing pneumonia and typhoid vaccines as well as new TB and pneumonia vaccines that are currently in clinical trials, could save over half a million deaths annually from drug resistant pathogens that don’t respond to antibiotics, according to a new WHO report on how vaccine strategies can reduce antimicrobial resistance (AMR). And […] Continue reading -> Alzheimer’s Advocates Urge G7 to Accelerate Research and Healthcare Preparedness 09/10/2024 Maayan Hoffman Helen Rochford-Brennan, a 72-year-old Irish woman living with Alzheimer’s, was first diagnosed at 57, with a more complete diagnosis following five years later. At the time, there were no life-enhancing medications, leaving her to face the grim reality of her brain’s gradual decline, enduring what she described as “many dark days.” “Imagine having a new […] Continue reading -> Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> World Leaders Approve Milestone Commitment to Reduce Deaths from Antibiotic Resistance by 10% by 2030 26/09/2024 Elaine Ruth Fletcher A UN High Level Meeting on Antimicrobial Resistance (AMR) pledged to reduce by 10% deaths from drug resistant bacteria over the next six years in a new declaration on the “silent, slow-motion pandemic” that could kill some 39 million more people by 2050. Thursday’s milestone statement, the first on the topic since 2016, also pledges […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Alzheimer’s Advocates Urge G7 to Accelerate Research and Healthcare Preparedness 09/10/2024 Maayan Hoffman Helen Rochford-Brennan, a 72-year-old Irish woman living with Alzheimer’s, was first diagnosed at 57, with a more complete diagnosis following five years later. At the time, there were no life-enhancing medications, leaving her to face the grim reality of her brain’s gradual decline, enduring what she described as “many dark days.” “Imagine having a new […] Continue reading -> Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> World Leaders Approve Milestone Commitment to Reduce Deaths from Antibiotic Resistance by 10% by 2030 26/09/2024 Elaine Ruth Fletcher A UN High Level Meeting on Antimicrobial Resistance (AMR) pledged to reduce by 10% deaths from drug resistant bacteria over the next six years in a new declaration on the “silent, slow-motion pandemic” that could kill some 39 million more people by 2050. Thursday’s milestone statement, the first on the topic since 2016, also pledges […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> World Leaders Approve Milestone Commitment to Reduce Deaths from Antibiotic Resistance by 10% by 2030 26/09/2024 Elaine Ruth Fletcher A UN High Level Meeting on Antimicrobial Resistance (AMR) pledged to reduce by 10% deaths from drug resistant bacteria over the next six years in a new declaration on the “silent, slow-motion pandemic” that could kill some 39 million more people by 2050. Thursday’s milestone statement, the first on the topic since 2016, also pledges […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Gilead Urged to Expand Voluntary Licences for its Breakthrough HIV Treatment 03/10/2024 Kerry Cullinan HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment, lenacapavir, in 120 low- and middle-income countries. However, they have urged Gilead to expand the deal to include countries such as Brazil, Colombia and Mexico. Lenacapavir is a long-acting injectable drug that […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> World Leaders Approve Milestone Commitment to Reduce Deaths from Antibiotic Resistance by 10% by 2030 26/09/2024 Elaine Ruth Fletcher A UN High Level Meeting on Antimicrobial Resistance (AMR) pledged to reduce by 10% deaths from drug resistant bacteria over the next six years in a new declaration on the “silent, slow-motion pandemic” that could kill some 39 million more people by 2050. Thursday’s milestone statement, the first on the topic since 2016, also pledges […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> World Leaders Approve Milestone Commitment to Reduce Deaths from Antibiotic Resistance by 10% by 2030 26/09/2024 Elaine Ruth Fletcher A UN High Level Meeting on Antimicrobial Resistance (AMR) pledged to reduce by 10% deaths from drug resistant bacteria over the next six years in a new declaration on the “silent, slow-motion pandemic” that could kill some 39 million more people by 2050. Thursday’s milestone statement, the first on the topic since 2016, also pledges […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO’s mRNA Vaccine Hub Faces ‘Uncertainty and Structural Weaknesses’ 30/09/2024 Kerry Cullinan The establishment of an “mRNA hub” in South Africa to build the capacity of low- and middle-income countries (LMICs) to develop vaccines during the COVID-19 pandemic was widely hailed as a solution to Africa’s lack of manufacturing ability. But three years after its launch in June 2021, the hub faces uncertainties, risks and shortfalls – […] Continue reading -> World Leaders Approve Milestone Commitment to Reduce Deaths from Antibiotic Resistance by 10% by 2030 26/09/2024 Elaine Ruth Fletcher A UN High Level Meeting on Antimicrobial Resistance (AMR) pledged to reduce by 10% deaths from drug resistant bacteria over the next six years in a new declaration on the “silent, slow-motion pandemic” that could kill some 39 million more people by 2050. Thursday’s milestone statement, the first on the topic since 2016, also pledges […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
World Leaders Approve Milestone Commitment to Reduce Deaths from Antibiotic Resistance by 10% by 2030 26/09/2024 Elaine Ruth Fletcher A UN High Level Meeting on Antimicrobial Resistance (AMR) pledged to reduce by 10% deaths from drug resistant bacteria over the next six years in a new declaration on the “silent, slow-motion pandemic” that could kill some 39 million more people by 2050. Thursday’s milestone statement, the first on the topic since 2016, also pledges […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Mpox and Cholera Outbreaks Underscore Importance of Gavi’s African Vaccine Initiative – But Can it Ensure Equity? 10/09/2024 Kerry Cullinan While COVID exposed the urgency of ensuring that Africa can manufacture vaccines, the current mpox and cholera outbreaks have painfully underscored the continent’s vulnerability. African countries affected by mpox are dependent on vaccine donations from wealthy countries, while a dire global shortage of cholera vaccines has forced the World Health Organization (WHO) to advise countries […] Continue reading -> Posts navigation Older postsNewer posts